News

Filter

Current filters:

GentiumRare diseases

1 to 9 of 95882 results

Animal data show positive results in Marburg virus with Tekmira’s LNP

21-08-2014

Canadian RNA interference (RNAi) therapeutics developer Tekmira Pharmaceuticals has highlighted the publication…

Anti-viralsPharmaceuticalResearchTekmira PharmaceuticalsTKM-Ebola

Positive top-line Ph III results for Baxter’s BAX 855 in hemophilia A

21-08-2014

US drugmaker Baxter International has announced positive results from its Phase III pivotal clinical…

AdvateBAX 855Baxter InternationalHematologyPharmaceuticalRegulationResearch

Payers exert cost controls on high-cost biologics to treat autoimmune conditions

21-08-2014

Surveyed managed care organizations (MCOs) anticipate that their costs of covering biologic treatments…

Anti-Arthritics/RheumaticsBiotechnologyFinancialHealthcareImmunologicals

Positive Ph III data for Amicus’ migalastat as Fabry monotherapy

21-08-2014

US biopharma company Amicus Therapeutics has revealed positive 18-month data from its second Phase III…

Amicus TherapeuticsBiotechnologymigalastatRare diseasesRegulationResearch

Grattan Institute admission shows Australia’s PBS savings proposal was wrong

21-08-2014

The Grattan Institute’s proposal on Australia Pharmaceutical Benefits Scheme (PBS) savings has been…

AustraliaFinancialPharmaceuticalPricing

Public Citizen expert slams aspects of FDA draft drug labeling guidance

21-08-2014

The US Food and Drug Administration recently issued draft guidance that would let the pharmaceutical…

PharmaceuticalRegulationUSA

US federal court issues restraining order against FDA's approval for generics of Hospira's Precedex

US federal court issues restraining order against FDA's approval for generics of Hospira's Precedex

21-08-2014

A judge in US federal court has issued a temporary restraining order following the US Food & Drug Administration’s…

Food and Drug AdministrationHospiraMylanNeurologicalPharmaceuticalPrecedexUSA

1 to 9 of 95882 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top